Results 201 to 210 of about 164,097 (264)

Validation of the International Weed Genomics Consortium genome annotation pipeline through reannotation of the model species Arabidopsis thaliana

open access: yesThe Plant Genome, Volume 19, Issue 3, September 2026.
Abstract The International Weed Genomics Consortium (IWGC) has sequenced and annotated the genomes of over 30 weed species, generating genomic resources to understand their biology, evolution, and adaptation. The objective of this study was to evaluate the semi‐automated, isoform sequencing (Iso‐seq)‐based, IWGC genome annotation pipeline by ...
Luan Cutti   +9 more
wiley   +1 more source

Systematic identification of disease-causing promoter and untranslated region variants in 8,040 undiagnosed individuals with rare disease

open access: yes, 2023
Martin-Geary AC   +21 more
europepmc   +1 more source

Comparative analysis of microRNAs in bovine colostrum and neonatal calf blood

open access: yesJournal of the Science of Food and Agriculture, Volume 106, Issue 10, Page 5799-5809, 15 August 2026.
Abstract BACKGROUND MicroRNAs (miRNAs) are short non‐coding RNAs that participate in a wide range of biological processes. MiRNAs are present in high concentrations in colostrum, and these may be potentially transferred to newborn calves being fed colostrum.
Do T Hue   +7 more
wiley   +1 more source

The power of many: when genetics met yeasts and high‐throughput

open access: yesBiological Reviews, Volume 101, Issue 4, Page 1662-1682, August 2026.
ABSTRACT In recent years, complex technological capabilities have evolved, driven by the need to solve complex and integrative biological questions through global analyses. New equipment allows the scaling up and automation of processes which previously were carried out on a very limited scale.
Víctor A. Tallada, Víctor Carranco
wiley   +1 more source

PharmVar GeneFocus: CYP1A2—Clinical Impact, Genetic Variation, and Updated Nomenclature

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 313-323, August 2026.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP1A2 gene. CYP1A2 plays a crucial role in the biotransformation of several commonly used drugs, including antipsychotics, antidepressants, anxiolytics, and methylxanthines.
Katalin Monostory   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy